Mark U. Rarick

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

Parkash S. Gill, J Wernz, David T. Scadden et al. · Journal of Clinical Oncology · 1996 · 439 citations

Medicine, Oncology, Pharmacology +10

Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology

J. Douglas Rizzo, Alan Lichtin, Steven H. Woolf et al. · Journal of Clinical Oncology · 2002 · 418 citations

Pharmacy, Oncology, Pharmacotherapy +5

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update

J. Douglas Rizzo, Mark R. Somerfield, Karen L. Hagerty et al. · Journal of Clinical Oncology · 2007 · 324 citations · Full text

Medicine, Hematology, Oncology +13

AIDS-related malignant lymphoma: results of prospective treatment trials.

Parkash S. Gill, A Levine, Mark Krailo et al. · Journal of Clinical Oncology · 1987 · 196 citations

Medicine, Oncology, Pharmacotherapy +16